Ulrike Billmeier

1.9k total citations
16 papers, 847 citations indexed

About

Ulrike Billmeier is a scholar working on Immunology, Genetics and Epidemiology. According to data from OpenAlex, Ulrike Billmeier has authored 16 papers receiving a total of 847 indexed citations (citations by other indexed papers that have themselves been cited), including 12 papers in Immunology, 10 papers in Genetics and 4 papers in Epidemiology. Recurrent topics in Ulrike Billmeier's work include Inflammatory Bowel Disease (9 papers), IL-33, ST2, and ILC Pathways (5 papers) and Microscopic Colitis (4 papers). Ulrike Billmeier is often cited by papers focused on Inflammatory Bowel Disease (9 papers), IL-33, ST2, and ILC Pathways (5 papers) and Microscopic Colitis (4 papers). Ulrike Billmeier collaborates with scholars based in Germany, United Kingdom and Netherlands. Ulrike Billmeier's co-authors include Markus F. Neurath, Raja Atreya, Walburga Dieterich, Stefan Wirtz, Richard S. Blumberg, Timo Räth, Maximilian J. Waldner, Kai Hildner, Sophia Sonnewald and H Schmitt and has published in prestigious journals such as Journal of Clinical Investigation, The Journal of Immunology and Gastroenterology.

In The Last Decade

Ulrike Billmeier

16 papers receiving 838 citations

Peers

Ulrike Billmeier

IMMUN

GENET

EPIDE

SURGE

William G. Ross United States

A D Levine United States

Jodie Ouahed United States

P. Vavassori Italy

Kazuhito Sugimura Japan

Sharon B. Hoang United States

Seiji Arihiro Japan

Zhiqiong Yang United States

Thomas Griga Germany

Amir Karban Israel

William G. Ross United States

Ulrike Billmeier

579 ×1.3

IMMUN

384 ×1.0

GENET

213 ×1.1

EPIDE

251 ×1.3

173 ×1.4

SURGE

Citations per year, relative to Ulrike Billmeier Ulrike Billmeier (= 1×) peers William G. Ross

Countries citing papers authored by Ulrike Billmeier

Since Specialization

Citations

This map shows the geographic impact of Ulrike Billmeier's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ulrike Billmeier with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ulrike Billmeier more than expected).

Fields of papers citing papers by Ulrike Billmeier

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Ulrike Billmeier. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ulrike Billmeier. The network helps show where Ulrike Billmeier may publish in the future.

Co-authorship network of co-authors of Ulrike Billmeier

This figure shows the co-authorship network connecting the top 25 collaborators of Ulrike Billmeier. A scholar is included among the top collaborators of Ulrike Billmeier based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Ulrike Billmeier. Ulrike Billmeier is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

16 of 16 papers shown

Schmitt, H, Ulrike Billmeier, Michael Vieth, et al.. (2019). The TLR9 Agonist Cobitolimod Induces IL10-Producing Wound Healing Macrophages and Regulatory T Cells in Ulcerative Colitis. Journal of Crohn s and Colitis. 14(4). 508–524. 55 indexed citations

Schmitt, H, Ulrike Billmeier, Walburga Dieterich, et al.. (2018). Expansion of IL-23 receptor bearing TNFR2+ T cells is associated with molecular resistance to anti-TNF therapy in Crohn’s disease. Gut. 68(5). 814–828. 184 indexed citations

Räth, Timo, Ulrike Billmeier, Fulvia Ferrazzi, et al.. (2018). Effects of Anti-Integrin Treatment With Vedolizumab on Immune Pathways and Cytokines in Inflammatory Bowel Diseases. Frontiers in Immunology. 9. 1700–1700. 40 indexed citations

Schmitt, H, Ulrike Billmeier, Walburga Dieterich, et al.. (2017). Expansion of IL-23 Receptor Bearing TNFR2+ T Cells Drives Resistance to Anti-TNF Therapy in Crohn's Disease. Gastroenterology. 152(5). S759–S759. 1 indexed citations

Billmeier, Ulrike, Walburga Dieterich, Markus F. Neurath, & Raja Atreya. (2016). Molecular mechanism of action of anti-tumor necrosis factor antibodies in inflammatory bowel diseases. World Journal of Gastroenterology. 22(42). 9300–9300. 163 indexed citations

Atreya, Imke, Radovan Dvorský, Raja Atreya, et al.. (2016). Designer Thiopurine-analogues for Optimised Immunosuppression in Inflammatory Bowel Diseases. Journal of Crohn s and Colitis. 10(10). 1132–1143. 14 indexed citations

López-Posadas, Rocío, Christoph Becker, Claudia Günther, et al.. (2016). Rho-A prenylation and signaling link epithelial homeostasis to intestinal inflammation. Journal of Clinical Investigation. 126(2). 611–626. 34 indexed citations

Wittkopf, Nadine, Geethanjali Pickert, Ulrike Billmeier, et al.. (2015). Activation of Intestinal Epithelial Stat3 Orchestrates Tissue Defense during Gastrointestinal Infection. PLoS ONE. 10(3). e0118401–e0118401. 46 indexed citations

Räth, Timo, Ulrike Billmeier, Maximilian J. Waldner, Raja Atreya, & Markus F. Neurath. (2015). From physiology to disease and targeted therapy: interleukin-6 in inflammation and inflammation-associated carcinogenesis. Archives of Toxicology. 89(4). 541–554. 35 indexed citations

10.

Tel, Jurjen, Katrin Jozefowski, Katharina Lahl, et al.. (2015). Selective Expression of the MAPK Phosphatase Dusp9/MKP-4 in Mouse Plasmacytoid Dendritic Cells and Regulation of IFN-β Production. The Journal of Immunology. 195(4). 1753–1762. 8 indexed citations

11.

Billmeier, Ulrike, et al.. (2014). Tu1706 The TLR-9 Agonist DIMS0150 Leads to the Induction of IL-10 Positive Mucosal Cells in Ulcerative Colitis Patients. Gastroenterology. 146(5). S–822. 1 indexed citations

12.

Backert, Ingo, Sergei B. Koralov, Stefan Wirtz, et al.. (2014). STAT3 Activation in Th17 and Th22 Cells Controls IL-22–Mediated Epithelial Host Defense during Infectious Colitis. The Journal of Immunology. 193(7). 3779–3791. 66 indexed citations

13.

Stock, Michael, Christina Böhm, Carina Scholtysek, et al.. (2013). Wnt Inhibitory Factor 1 Deficiency Uncouples Cartilage and Bone Destruction in Tumor Necrosis Factor α–Mediated Experimental Arthritis. Arthritis & Rheumatism. 65(9). 2310–2322. 25 indexed citations

14.

Wirtz, Stefan, et al.. (2011). Interleukin-35 Mediates Mucosal Immune Responses That Protect Against T-Cell–Dependent Colitis. Gastroenterology. 141(5). 1875–1886. 173 indexed citations

15.

Wittkopf, Nadine, Ulrike Billmeier, Claudia Günther, et al.. (2011). STAT3-Mediated Production of Antimicrobial Peptides by Intestinal Epithelial Cells Helps Controlling C. rodentium Induced Infection. Gastroenterology. 140(5). S–325. 1 indexed citations

16.

Billmeier, Ulrike, Markus F. Neurath, & Stefan Wirtz. (2011). IL-23 is a Key Pathogenic Inducer of Chronic Intestinal Inflammation. Gastroenterology. 140(5). S–836. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact